Poor quality TB care is widespread and is a key driver of the TB epidemic. This course will address the critical need to go beyond coverage and improve quality of TB care in low and middle-income countries.
Madhukar Pai, MD, PhD
Canada Research Chair in Epidemiology & Global Health, McGill University
Associate Director, McGill International TB Centre
Zelalem Temesgen, MD
Director, Mayo Clinic Center for Tuberculosis
Jishnu Das, PhD
Professor, McCourt School of Public Policy and School of Foreign Service, Georgetown University
Bruce Agins, MD – UCSF & HealthQual
Hannah Alsdurf, PhD – University of Ottawa
Farhana Amanullah, MD – Indus Hospital and Health Network, Pakistan
Anurag Bhargava, MD – Yenepoya Medical College, India
Jody Boffa – Stellenbosch University, South Africa
Adithya Cattamanchi, MD – UCSF
Carmen Christian – University of Western Cape
Amrita Daftary, PhD, MPH – York University
Benjamin Daniels – Georgetown University
Makanda Goodman – Treatment Action Campaign, South Africa
Margaret Kruk, MD – Harvard T.H. Chan School of Public Health
Tenzin Kunor – We are TB, USA
Ada Kwan, PhD, MHS – University of California, San Francisco
Elysia Larson – Harvard T.H. Chan School of Public Health
Goodman Makanda – TB Proof & MSF, South Africa
Chapal Mehra – Survivors Against TB, India
Lindiwe Mvusi – National Department of Health, South Africa
Kogie Naidoo, MD – CAPRISA, South Africa
Aakriti Pandita – Colorado University, USA
Zolelwa Sifumba, MBBCh – TB Proof, South Africa
Guy Stallworthy – Bill & Melinda Gates Foundation
Ramnath Subbaraman, MD – Tufts University School of Medicine
Shibu Vijayan, MD – PATH, India
Faculty are still being confirmed and there may be changes to the above list.
In order to end TB, we need to increase access to TB care and simultaneously ensure that the care provided is of sufficiently high quality (i.e. care that is safe, effective, patient-centered,
timely, efficient, and equitable). There is plenty of evidence that quality of TB (and TB-HIV coinfection and MDR-TB) care is poor in many settings, and this is a key reason for the high mortality rate seen in LMICs. This means National TB programs need to think beyond coverage of TB services; they need to start measuring and systematically improving quality of TB care in LMICs. This session of leading international experts will:
• Discuss and debate the best approaches to measurement of quality of TB care
• Review data on quality of TB care and factors that drive variation in care
• Explore quality of TB care in private versus public sectors
• Give examples of quality improvement programs in TB as well as other areas of global health (e.g. from HIV/AIDS) that have worked or failed through case study lessons
• Explain the use of quality dashboards, audits and tools, and their likely impact on quality
• Give strategies for understanding and overcoming the pervasive know-do gap, including training, mentoring, incentives, and system-wide changes for high-quality health systems
By the end of the course, participants will be able to:
Maximum of 200 participants.
